Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with a pharmacy claim for IFN between 1/1/2007 and 12/31/2011. The date of the first observed claim will be defined as the index date
Patients with a melanoma diagnosis based on two medical claims prior to the index date
Patients with a procedure code for melanoma-related lymph node dissection before the index date
Patients ≥ 18 years of age on or before the index date
Patients with continuous benefit enrollment for at least 180 days before and after the index date
You may not be if
Patients with diagnosis of any other (primary) cancer during the 180-day pre-index period (excepting skin cancers and hematologic malignancies)
Patients with diagnosis of a secondary cancer during the 180-day pre-index period or on the index date (excepting lymph node metastasis to a site common for melanoma or an improbable site for any other primary cancer)
Patients who received systemic chemotherapy during the pre- or post-index period
